SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-122475
Filing Date
2019-04-26
Accepted
2019-04-26 16:32:55
Documents
5
Period of Report
2019-04-25
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d706633d8k.htm 8-K 38746
2 EX-3.1A d706633dex31a.htm EX-3.1A 5763
3 EX-3.1B d706633dex31b.htm EX-3.1B 4645
4 EX-3.1C d706633dex31c.htm EX-3.1C 40846
5 EX-3.2 d706633dex32.htm EX-3.2 18675
  Complete submission text file 0001193125-19-122475.txt   109938
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36407 | Film No.: 19772181
SIC: 2834 Pharmaceutical Preparations